Hotline: +86-18022463983    020-85206863

China Dermal Filler and Botolinum Toxin Market Report & Forecast 2021-2027

Published Date: 2021-09-09   |   Pages: 90   |   Tables: 102   |  Pharma & Healthcare

This report contains market size and forecasts of Dermal Filler and Botolinum Toxin in China, including the following market information:

China Dermal Filler and Botolinum Toxin Market Revenue, 2016-2021, 2022-2027, ($ millions)

China Dermal Filler and Botolinum Toxin Market Sales, 2016-2021, 2022-2027, (K MT)

China top five Dermal Filler and Botolinum Toxin companies in 2020 (%)

The global Dermal Filler and Botolinum Toxin market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The China Dermal Filler and Botolinum Toxin market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Dermal Filler and Botolinum Toxin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Dermal Filler and Botolinum Toxin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

China Dermal Filler and Botolinum Toxin Market Segment Percentages, By Type, 2020 (%)

Hyaluronic Acid Based Fillers

Non-Hyaluronic Acid Based Fillers

Botulinum Toxin

China Dermal Filler and Botolinum Toxin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

China Dermal Filler and Botolinum Toxin Market Segment Percentages, By Application, 2020 (%)

Aesthetic Restoration

Wrinkle Reduction

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermal Filler and Botolinum Toxin revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Dermal Filler and Botolinum Toxin revenues share in China market, 2020 (%)

Key companies Dermal Filler and Botolinum Toxin sales in China market, 2016-2021 (Estimated), (K MT)

Key companies Dermal Filler and Botolinum Toxin sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Allergan

Galderma

Merz Pharma GmbH & Co. KGaA

Anika Therapeutics

Suneva Medical

Contura

HUGEL

Grex Pharma

Daewoong Pharmaceuticals

Medy-Tox

TEOXANE Laboratories

SciVision Biotech

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 Dermal Filler and Botolinum Toxin Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 China Dermal Filler and Botolinum Toxin Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 China Dermal Filler and Botolinum Toxin Overall Market Size

2.1 China Dermal Filler and Botolinum Toxin Market Size: 2021 VS 2027

2.2 China Dermal Filler and Botolinum Toxin Revenue, Prospects & Forecasts: 2016-2027

2.3 China Dermal Filler and Botolinum Toxin Sales: 2016-2027

3 Company Landscape

3.1 Top Dermal Filler and Botolinum Toxin Players in China Market

3.2 Top China Dermal Filler and Botolinum Toxin Companies Ranked by Revenue

3.3 China Dermal Filler and Botolinum Toxin Revenue by Companies

3.4 China Dermal Filler and Botolinum Toxin Sales by Companies

3.5 China Dermal Filler and Botolinum Toxin Price by Manufacturer (2016-2021)

3.6 Top 3 and Top 5 Dermal Filler and Botolinum Toxin Companies in China Market, by Revenue in 2020

3.7 Manufacturers Dermal Filler and Botolinum Toxin Product Type

3.8 Tier 1, Tier 2 and Tier 3 Dermal Filler and Botolinum Toxin Players in China Market

3.8.1 List of Tier 1 Dermal Filler and Botolinum Toxin Companies in China

3.8.2 List of Tier 2 and Tier 3 Dermal Filler and Botolinum Toxin Companies in China

4 Sights by Type

4.1 Overview

4.1.1 By Type - China Dermal Filler and Botolinum Toxin Market Size Markets, 2021 & 2027

4.1.2 Hyaluronic Acid Based Fillers

4.1.3 Non-Hyaluronic Acid Based Fillers

4.1.4 Botulinum Toxin

4.2 By Type - China Dermal Filler and Botolinum Toxin Revenue & Forecasts

4.2.1 By Type - China Dermal Filler and Botolinum Toxin Revenue, 2016-2021

4.2.2 By Type - China Dermal Filler and Botolinum Toxin Revenue, 2022-2027

4.2.3 By Type - China Dermal Filler and Botolinum Toxin Revenue Market Share, 2016-2027

4.3 By Type - China Dermal Filler and Botolinum Toxin Sales & Forecasts

4.3.1 By Type - China Dermal Filler and Botolinum Toxin Sales, 2016-2021

4.3.2 By Type - China Dermal Filler and Botolinum Toxin Sales, 2022-2027

4.3.3 By Type - China Dermal Filler and Botolinum Toxin Sales Market Share, 2016-2027

4.4 By Type - China Dermal Filler and Botolinum Toxin Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - China Dermal Filler and Botolinum Toxin Market Size, 2021 & 2027

5.1.2 Aesthetic Restoration

5.1.3 Wrinkle Reduction

5.2 By Application - China Dermal Filler and Botolinum Toxin Revenue & Forecasts

5.2.1 By Application - China Dermal Filler and Botolinum Toxin Revenue, 2016-2021

5.2.2 By Application - China Dermal Filler and Botolinum Toxin Revenue, 2022-2027

5.2.3 By Application - China Dermal Filler and Botolinum Toxin Revenue Market Share, 2016-2027

5.3 By Application - China Dermal Filler and Botolinum Toxin Sales & Forecasts

5.3.1 By Application - China Dermal Filler and Botolinum Toxin Sales, 2016-2021

5.3.2 By Application - China Dermal Filler and Botolinum Toxin Sales, 2022-2027

5.3.3 By Application - China Dermal Filler and Botolinum Toxin Sales Market Share, 2016-2027

5.4 By Application - China Dermal Filler and Botolinum Toxin Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

6.1 Allergan

6.1.1 Allergan Corporation Information

6.1.2 Allergan Overview

6.1.3 Allergan Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.1.4 Allergan Dermal Filler and Botolinum Toxin Product Description

6.1.5 Allergan Recent Developments

6.2 Galderma

6.2.1 Galderma Corporation Information

6.2.2 Galderma Overview

6.2.3 Galderma Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.2.4 Galderma Dermal Filler and Botolinum Toxin Product Description

6.2.5 Galderma Recent Developments

6.3 Merz Pharma GmbH & Co. KGaA

6.3.1 Merz Pharma GmbH & Co. KGaA Corporation Information

6.3.2 Merz Pharma GmbH & Co. KGaA Overview

6.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Description

6.3.5 Merz Pharma GmbH & Co. KGaA Recent Developments

6.4 Anika Therapeutics

6.4.1 Anika Therapeutics Corporation Information

6.4.2 Anika Therapeutics Overview

6.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Description

6.4.5 Anika Therapeutics Recent Developments

6.5 Suneva Medical

6.5.1 Suneva Medical Corporation Information

6.5.2 Suneva Medical Overview

6.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Product Description

6.5.5 Suneva Medical Recent Developments

6.6 Contura

6.6.1 Contura Corporation Information

6.6.2 Contura Overview

6.6.3 Contura Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.6.4 Contura Dermal Filler and Botolinum Toxin Product Description

6.6.5 Contura Recent Developments

6.7 HUGEL

6.7.1 HUGEL Corporation Information

6.7.2 HUGEL Overview

6.7.3 HUGEL Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.7.4 HUGEL Dermal Filler and Botolinum Toxin Product Description

6.7.5 HUGEL Recent Developments

6.8 Grex Pharma

6.8.1 Grex Pharma Corporation Information

6.8.2 Grex Pharma Overview

6.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Product Description

6.8.5 Grex Pharma Recent Developments

6.9 Daewoong Pharmaceuticals

6.9.1 Daewoong Pharmaceuticals Corporation Information

6.9.2 Daewoong Pharmaceuticals Overview

6.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Description

6.9.5 Daewoong Pharmaceuticals Recent Developments

6.10 Medy-Tox

6.10.1 Medy-Tox Corporation Information

6.10.2 Medy-Tox Overview

6.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Product Description

6.10.5 Medy-Tox Recent Developments

6.11 TEOXANE Laboratories

6.11.1 TEOXANE Laboratories Corporation Information

6.11.2 TEOXANE Laboratories Overview

6.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Description

6.11.5 TEOXANE Laboratories Recent Developments

6.12 SciVision Biotech

6.12.1 SciVision Biotech Corporation Information

6.12.2 SciVision Biotech Overview

6.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales and Revenue in China Market (2016-2021)

6.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Product Description

6.12.5 SciVision Biotech Recent Developments

7 China Dermal Filler and Botolinum Toxin Production Capacity, Analysis

7.1 China Dermal Filler and Botolinum Toxin Production Capacity, 2016-2027

7.2 Dermal Filler and Botolinum Toxin Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

8.1 Market Opportunities & Trends

8.2 Market Drivers

8.3 Market Restraints

9 Dermal Filler and Botolinum Toxin Supply Chain Analysis

9.1 Dermal Filler and Botolinum Toxin Industry Value Chain

9.2 Dermal Filler and Botolinum Toxin Upstream Market

9.3 Dermal Filler and Botolinum Toxin Downstream and Clients

9.4 Marketing Channels Analysis

9.4.1 Marketing Channels

9.4.2 Dermal Filler and Botolinum Toxin Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

11.1 Note

11.2 Examples of Clients

11.3 Author Details

11.4 Disclaimer

List of Tables

Table 1. Key Players of Dermal Filler and Botolinum Toxin in China Market

Table 2. Top Dermal Filler and Botolinum Toxin Players in China Market, Ranking by Revenue (2019)

Table 3. China Dermal Filler and Botolinum Toxin Revenue by Companies, (US$, Mn), 2016-2021

Table 4. China Dermal Filler and Botolinum Toxin Revenue Share by Companies, 2016-2021

Table 5. China Dermal Filler and Botolinum Toxin Sales by Companies, (K MT), 2016-2021

Table 6. China Dermal Filler and Botolinum Toxin Sales Share by Companies, 2016-2021

Table 7. Key Manufacturers Dermal Filler and Botolinum Toxin Price (2016-2021) & (USD/MT)

Table 8. Manufacturers Dermal Filler and Botolinum Toxin Product Type

Table 9. List of Tier 1 Dermal Filler and Botolinum Toxin Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 Dermal Filler and Botolinum Toxin Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. Major Manufacturers of Hyaluronic Acid Based Fillers

Table 12. Major Manufacturers of Non-Hyaluronic Acid Based Fillers

Table 13. By Type – China Dermal Filler and Botolinum Toxin Revenue, (US$, Mn), 2021 & 2027

Table 14. By Type - China Dermal Filler and Botolinum Toxin Revenue (US$, Mn), 2016-2021

Table 15. By Type - China Dermal Filler and Botolinum Toxin Revenue (US$, Mn), 2022-2027

Table 16. By Type - China Dermal Filler and Botolinum Toxin Sales (K MT), 2016-2021

Table 17. By Type - China Dermal Filler and Botolinum Toxin Sales (K MT), 2022-2027

Table 18. By Application – China Dermal Filler and Botolinum Toxin Revenue, (US$, Mn), 2021 VS 2027

Table 19. By Application - China Dermal Filler and Botolinum Toxin Revenue (US$, Mn), 2016-2021

Table 20. By Application - China Dermal Filler and Botolinum Toxin Revenue (US$, Mn), 2022-2027

Table 21. By Application - China Dermal Filler and Botolinum Toxin Sales (K MT), 2016-2021

Table 22. By Application - China Dermal Filler and Botolinum Toxin Sales (K MT), 2022-2027

Table 23. Allergan Corporation Information

Table 24. Allergan Description and Major Businesses

Table 25. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 26. Allergan Dermal Filler and Botolinum Toxin Product

Table 27. Allergan Recent Developments

Table 28. Galderma Corporation Information

Table 29. Galderma Description and Major Businesses

Table 30. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 31. Galderma Dermal Filler and Botolinum Toxin Product

Table 32. Galderma Recent Developments

Table 33. Merz Pharma GmbH & Co. KGaA Corporation Information

Table 34. Merz Pharma GmbH & Co. KGaA Description and Major Businesses

Table 35. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 36. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product

Table 37. Merz Pharma GmbH & Co. KGaA Recent Developments

Table 38. Anika Therapeutics Corporation Information

Table 39. Anika Therapeutics Description and Major Businesses

Table 40. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 41. Anika Therapeutics Dermal Filler and Botolinum Toxin Product

Table 42. Anika Therapeutics Recent Developments

Table 43. Suneva Medical Corporation Information

Table 44. Suneva Medical Description and Major Businesses

Table 45. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 46. Suneva Medical Dermal Filler and Botolinum Toxin Product

Table 47. Suneva Medical Recent Developments

Table 48. Contura Corporation Information

Table 49. Contura Description and Major Businesses

Table 50. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 51. Contura Dermal Filler and Botolinum Toxin Product

Table 52. Contura Recent Developments

Table 53. HUGEL Corporation Information

Table 54. HUGEL Description and Major Businesses

Table 55. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 56. HUGEL Dermal Filler and Botolinum Toxin Product

Table 57. HUGEL Recent Developments

Table 58. Grex Pharma Corporation Information

Table 59. Grex Pharma Description and Major Businesses

Table 60. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 61. Grex Pharma Dermal Filler and Botolinum Toxin Product

Table 62. Grex Pharma Recent Developments

Table 63. Daewoong Pharmaceuticals Corporation Information

Table 64. Daewoong Pharmaceuticals Description and Major Businesses

Table 65. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 66. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product

Table 67. Daewoong Pharmaceuticals Recent Developments

Table 68. Medy-Tox Corporation Information

Table 69. Medy-Tox Description and Major Businesses

Table 70. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 71. Medy-Tox Dermal Filler and Botolinum Toxin Product

Table 72. Medy-Tox Recent Developments

Table 73. TEOXANE Laboratories Corporation Information

Table 74. TEOXANE Laboratories Description and Major Businesses

Table 75. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 76. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product

Table 77. TEOXANE Laboratories Recent Developments

Table 78. SciVision Biotech Corporation Information

Table 79. SciVision Biotech Description and Major Businesses

Table 80. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

Table 81. SciVision Biotech Dermal Filler and Botolinum Toxin Product

Table 82. SciVision Biotech Recent Developments

Table 83. Dermal Filler and Botolinum Toxin Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)

Table 84. China Dermal Filler and Botolinum Toxin Capacity Market Share of Key Manufacturers, 2019-2021

Table 85. Dermal Filler and Botolinum Toxin Market Opportunities & Trends in China Market

Table 86. Dermal Filler and Botolinum Toxin Market Drivers in China Market

Table 87. Dermal Filler and Botolinum Toxin Market Restraints in China Market

Table 88. Dermal Filler and Botolinum Toxin Raw Materials

Table 89. Dermal Filler and Botolinum Toxin Raw Materials Suppliers in China Market

Table 90. Typical Dermal Filler and Botolinum Toxin Downstream

Table 91. Dermal Filler and Botolinum Toxin Downstream Clients in China Market

Table 92. Dermal Filler and Botolinum Toxin Distributors and Sales Agents in China Market

List of Figures

Figure 1. Dermal Filler and Botolinum Toxin Product Picture

Figure 2. Dermal Filler and Botolinum Toxin Segment by Type

Figure 3. Dermal Filler and Botolinum Toxin Segment by Application

Figure 4. China Dermal Filler and Botolinum Toxin Market Overview: 2020

Figure 5. China Dermal Filler and Botolinum Toxin Market Size: 2021 VS 2027 (US$, Mn)

Figure 6. China Dermal Filler and Botolinum Toxin Revenue, 2016-2027 (US$, Mn)

Figure 7. Dermal Filler and Botolinum Toxin Sales in China Market: 2016-2027 (K MT)

Figure 8. The Top 3 and 5 Players Market Share by Dermal Filler and Botolinum Toxin Revenue in 2020

Figure 9. Hyaluronic Acid Based Fillers Product Picture

Figure 10. Non-Hyaluronic Acid Based Fillers Product Picture

Figure 11. Botulinum Toxin Product Picture

Figure 12. By Type - China Dermal Filler and Botolinum Toxin Sales Market Share, 2016-2027

Figure 13. By Type - China Dermal Filler and Botolinum Toxin Revenue Market Share, 2016-2027

Figure 14. By Type - China Dermal Filler and Botolinum Toxin Price (USD/MT), 2016-2027

Figure 15. Aesthetic Restoration

Figure 16. Wrinkle Reduction

Figure 17. By Application - China Dermal Filler and Botolinum Toxin Sales Market Share, 2016-2027

Figure 18. By Application - China Dermal Filler and Botolinum Toxin Revenue Market Share, 2016-2027

Figure 19. By Application - China Dermal Filler and Botolinum Toxin Price (USD/MT), 2016-2027

Figure 20. Allergan Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 21. Galderma Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 22. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 23. Anika Therapeutics Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 24. Suneva Medical Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 25. Contura Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 26. HUGEL Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 27. Grex Pharma Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 28. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 29. Medy-Tox Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 30. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 31. SciVision Biotech Dermal Filler and Botolinum Toxin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 32. China Dermal Filler and Botolinum Toxin Production Capacity (K MT), 2016-2027

Figure 33. Dermal Filler and Botolinum Toxin Industry Value Chain

Figure 34. Marketing Channels

Our Clients